Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Amends PerkinElmer Distribution Deal

NEW YORK, Jan. 10—Genomic Solutions has amended its distribution deal with PerkinElmer Life Sciences, the company said Thursday.

 

Under the new agreement, PerkinElmer will have non-exclusive rights to market and distribute all Genomic Solutions products outside the U.S. and Japan, and assumes non-exclusive distribution rights worldwide for Genomic Solution's Investigator proteomic electrophoresis products. the company's GeneTAC HybStation, and all Cartesian Technologies products.

 

The two companies have had a comprehensive sales, distribution, and technology alliances since December 1999, when PerkinElmer made an equity investment in the company. After settling a lawsuit regarding that equity stake in spring 2001, the firms expanded that arrangement.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.